“Cannabis benefits patients with inflammatory bowel disease (IBD).
Cannabinoid receptors are expressed in gut immune cells and in epithelial cells of inflamed guts.
Mucosal healing (MH) requires epithelial layer restoration.
CONCLUSION:
Using ex vivo and in vitro human models, we demonstrated that manipulating the cannabinoid system affects colon cells and secretome characteristics that facilitate MH in IBD.”
https://www.ncbi.nlm.nih.gov/pubmed/32213014
“Experimental studies and recent clinical trials suggest that treatment with cannabis benefits patients with IBD.”